Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SAJAZIR™ (icatibant) safely and effectively. See full prescribing information for SAJAZIR™.SAJAZIR™ (icatibant) injection, for subcutaneous useInitial U.S. Approval: 2011
Medication labelWhy this: Advisory · dailymed-prescription
SAJAZIR (icatibant) injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
- generic_name
- icatibant
- product_names
- ICATIBANT
- ndc
- 70709-013, 70709-013-03, 70709-013-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en